Raymond James & Associates’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $188K | Buy |
|
|||||
|
2024
Q2 | $115K | Sell |
|
|||||
|
2024
Q1 | $118K | Buy |
|
|||||
|
2023
Q4 | $115K | Sell |
|
|||||
|
2023
Q3 | $341K | Sell |
|
|||||
|
2023
Q2 | $435K | Buy |
|
|||||
|
2023
Q1 | $267K | Buy |
|
|||||
|
2022
Q4 | $179K | Sell |
|
|||||
|
2022
Q3 | $144K | Sell |
|
|||||
|
2022
Q2 | $125K | Buy |
|
|||||
|
2022
Q1 | $117K | Buy |
|
|||||
|
2021
Q4 | $87K | Sell |
|
|||||
|
2021
Q3 | $403K | Sell |
|
|||||
|
2021
Q2 | $525K | Buy |
|
|||||
|
2021
Q1 | $265K | Sell |
|
|||||
|
2020
Q4 | $156K | Hold |
|
|||||
|
2020
Q3 | $169K | Buy |
|
|||||
|
2020
Q2 | $92K | Sell |
|
|||||
|
2020
Q1 | $61K | Buy |
|
|||||
|
2019
Q4 | $131K | Buy |
|
|||||
|
2019
Q3 | $117K | Buy |
|
|||||
|
2019
Q2 | $103K | Buy |
|